[Immunogenetic factors in pulmonary tuberculosis surgery]

Area of Science:

• Immunogenetics
• Clinical Medicine
• Surgical Oncology

Context:

• Tuberculosis (TB) remains a significant global health challenge, particularly in patients with a history of surgery.
• Understanding host genetic factors, such as human leukocyte antigen (HLA) and haptoglobin (Hp) phenotypes, may offer insights into TB susceptibility and outcomes.
• Fibrocavernous tuberculosis and tuberculomas represent distinct clinical manifestations requiring surgical intervention.

Purpose:

• To investigate the association between specific human leukocyte antigen (HLA) antigens, haptoglobin (Hp) phenotypes, ABO blood groups, and rhesus factor in patients with surgically treated tuberculosis.
• To identify potential genetic markers that correlate with the incidence of tuberculosis, postoperative complications, and disease recurrence.

Summary:

• A study of 60 fibrocavernous tuberculosis patients and 50 tuberculoma patients revealed distinct genetic profiles.
• Tuberculosis patients more frequently carried HLA antigens B27 and DR2, HP 2-2, and blood group O (I).
• Tuberculoma patients showed higher frequencies of HLA antigens A1, B12, and DR3, while HLA A2 was less frequent. HLA antigen DR2 was associated with increased postoperative TB reactivation and recurrence.

Impact:

• Identifies specific HLA antigens (DR2) and Hp types (HP 2-2) as potential risk factors for tuberculosis reactivation and recurrence after surgery.
• Suggests that HLA and Hp typing could potentially inform patient stratification and postoperative management strategies for tuberculosis.
• Highlights the need for further research into the immunogenetic basis of tuberculosis to improve clinical outcomes.